Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD63 Antibody (446703), DyLight 755, Novus Biologicals™
SDP

Rat Monoclonal Antibody

Supplier:  Novus Biologicals FAB5417Z

Catalog No. NB368034


Only null left
Add to Cart

Description

Description

CD63 Monoclonal antibody specifically detects CD63 in Mouse samples. It is validated for Flow Cytometry, Immunohistochemistry, CyTOF
Specifications

Specifications

CD63
Monoclonal
DyLight 755
50mM Sodium Borate
Rat
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Mouse
Purified
Flow Cytometry, Immunohistochemistry, CyTOF
446703
Flow Cytometry, Immunohistochemistry, CyTOF-ready
CD_antigen: CD63, CD63, CD63 antigen, CD63 antigen (melanoma 1 antigen), CD63 molecule, Granulophysin, LAMP-3, Lysosomal-associated membrane protein 3, lysosome-associated membrane glycoprotein 3, ME491, melanoma 1 antigen, Melanoma-associated antigen ME491, melanoma-associated antigen MLA1, MLA1, Ocular melanoma-associated antigen, OMA81H, Tetraspanin-30, tspan-30, Tspan30
HEK293 human embryonic kidney cell line transfected with mouse CD63, Met1-Met238, Accession # P41731
0.1 mL
Autophagy, Cancer, Cardiovascular Biology, Cellular Signaling, Cytokine Research, Immunology, Innate Immunity, Lysosome Markers, Metastasis
967
Store at 4°C in the dark.
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.